FindMyKOL
Clinical trialNCT05077384CompletedPhase 1/PHASE2Interventional

Open-label Study of Surufatinib in Japanese Patients

SponsorHutchmedEnrollment36Neuroendocrine TumorsNon-hematologic Malignancy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase 1/2, open-label, multi-centre study of surufatinib in patients with unresectable, locally advanced, or recurrent nonhematologic malignancies who do not respond or are intolerant to standard of care.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Japan
  • Fukuoka Sanno Hospital

    Fukuoka, Japan

  • Kyushu University Hospital

    Fukuoka, Japan

  • Kagawa University Hospital

    Kagawa, Japan

  • National Cancer Centre Hospital East

    Kashiwa-shi, Japan

  • Kyoto University Hospital

    Kyoto, Japan

  • Kyorin University Hospital

    Mitaka, Japan

  • Aichi Cancer Centre

    Nagoya, Japan

  • Kansia Electric Power Hospital

    Osaka, Japan

  • Hokkaido University Hospital

    Sapporo, Japan

  • Tohoku University Hospital

    Sendai, Japan

  • National Cancer Centre Hospital

    Tokyo, Japan

  • Yokohama City University Hospital

    Yokohama, Japan

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Surufatinib
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Sept 2021
Primary completion
6 Sept 2024
Completion
17 Jan 2025
Last update posted
16 Sept 2025
Registered enrollment
36
Registry id
NCT05077384
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.